$XENE
Xenon Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
$37.79
▼-0.61%-$0.233
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateXenon Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is XENE down today? It is at $37.79 (-0.61%), and our scanner flagged it 144 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment XENE spikes, and full due diligence on XENE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $XENE 144 times in the last 30 days. Create a free account to track $XENE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on XENE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for XENE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Oct 1, 2026 · 4 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
13,114,037 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mortimer Ian Officer | Bought (open market) | +30K 0.03% of company | added 100% | 50K | $1.1M at $37.38 | Sep 30, 26 |
Kelly Thomas Patrick Officer | Bought (open market) | +15K 0.02% of company | n/a | 15K | $560K at $37.32 | Sep 30, 26 |
Svoronos Dawn Director | Other | 5K | added 20% | 31K | $42K at $8.15 | Sep 1, 26 |
Kenney Christopher John Officer | Sold (automatic/other) | -7K | sold 100% | 2 | $425K at $60.17 | Aug 28, 26 |
Gannon Steven Director | Sold (automatic/other) | -10K 0.01% of company | sold 84% | 2K | $641K at $64.06 | Aug 11, 26 |
Cannon Gillian Director | Sold (automatic/other) | -1K | sold 45% | 1K | $63K at $53.14 | Jun 5, 26 |
Patou Gary Director | Sold (automatic/other) | -1K | sold 5.0% | 25K | $70K at $53.14 | Jun 5, 26 |
Svoronos Dawn Director | Sold (automatic/other) | -1K | sold 5.1% | 26K | $76K at $53.41 | Jun 1, 26 |
Svoronos Dawn Director | Other | 3K | added 11% | 28K | n/a | Jun 1, 26 |
Cannon Gillian Director | Other | 3K | n/a | 3K | n/a | Jun 1, 26 |
Gannon Steven Director | Sold (automatic/other) | -1K | sold 11% | 12K | $76K at $53.41 | Jun 1, 26 |
Gannon Steven Director | Other | 3K | added 25% | 13K | n/a | Jun 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on XENE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for XENE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
XENE last traded at $37.79, down 0.61% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Xenon Pharmaceuticals Inc (XENE) is next expected to report earnings on Monday, November 2, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The XENE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged XENE 144 times in the last 30 days.
XENE (Xenon Pharmaceuticals Inc) trades on XNAS, with a market cap of about $3.64B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge XENE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$XENE discussion
Sign in to ask a question or join the discussion.